This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:

This review aims to look at the benefits and harms of calcineurin inhibitor tapering or withdrawal in terms of graft function and loss, incidence of acute rejection episodes, treatment‐related side effects (hypertension, hyperlipidaemia) and mortality.